The Latest Cardiac and Vascular News
Abelacimab is a dual-acting fully human monoclonal antibody targeting both Factor XI and Factor XIa with high affinity and selectivity Earlier this year abelacimab became the first-ever Factor XI inhibitor to begin enrolling patients in a Phase 3 trial (The ASTER Study) The AZALEA-TIMI 71 trial in patients with atrial fibrillation […]
CHICAGO, July 11, 2022 /PRNewswire/ — The International Society for Heart and Lung Transplantation (ISHLT) named Rebecca Cogswell, MD, the Medical Director of the Society’s International Thoracic Organ Transplant (TTX) Registry. The search process was led by the ISHLT Research Oversight Committee, chaired by Jason Christie, MD, MS. Dr. Cogswell is Associate Professor of Medicine, […]
Its new Cardiac Center of Excellence and Imaging Excellence Advisory Services are designed to support radiology departments nationwide Louisville, KY, July 11, 2022 (GLOBE NEWSWIRE) — 3DR Labs, an Accumen company, today announced the launch of its Cardiac Center of Excellence and Imaging Excellence Advisory Services to support radiology departments […]
ST. LOUIS, July 11, 2022 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the CE Mark submission for its MAGiC™ catheter. The MAGiC catheter is a robotically navigated magnetic interventional ablation catheter for minimally invasive cardiac ablation procedures. Used […]
PARIS–(BUSINESS WIRE)–Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 – ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies, today discloses the total number of voting rights and shares as of June 30, 2022 (pursuant to Article L. 233-8 II of the French Commercial […]
New health economics research on polygenic risk score (PRS) for cardiovascular disease published in the Journal of the American Heart Association highlights the cost savings of PRS testing for US healthcare systems NEW YORK, July 7, 2022 /PRNewswire/ — Allelica, a leading genomic software company specializing in secure and scalable solutions to implement […]
Westport, CT, July 07, 2022 (GLOBE NEWSWIRE) — OPRMC marks our first leasing agreement under new program Company also inks national master agreement with one of the largest U.S. healthcare systems BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow by delivering greater […]
Tenaya’s Precision Medicine Platform Used to Identify HDAC6 Target Using Phenotypic Screening and Machine Learning Algorithms Tenaya’s HDAC6 Inhibitor TN-301 Advancing to the Clinic for HFpEF, with IND Filing on Track for 2H 2022 SOUTH SAN FRANCISCO, Calif., July 06, 2022 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a […]
MINNEAPOLIS–(BUSINESS WIRE)–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that the U.S. Food and Drug Administration (FDA) has placed a clinical hold on the Company’s Phase 2/3 ReMEDy2 trial studying the use of the Company’s product […]
LAKE OSWEGO, Ore., July 6, 2022 /PRNewswire/ — BIOTRONIK’s state-of-the-art LiveSupport feature was used to remotely support two BIOMONITOR Implantable Cardiac Monitor (ICM) implants shortly after launch. Both procedures were performed with a BIOTRONIK representative in a remote location. The physicians are pleased with the results and the support offered; they are […]
